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Abstract Aerolysin, a virulence factor secreted by Aeromonas 
hydrophila, is representative of a group of ~-sheet oxins that 
must form stable homooligomers in order to be able to insert into 
biological membranes and generate channels. Electron micro- 
scopy and image analysis of two-dimensional membrane crystals 
had previously revealed a structure with 7-fold symmetry 
suggesting that aerolysin forms heptameric oligomers [Wilmsen 
et al. (1992) EMBO J. 11, 2457-24631. However, this unusual 
molecularity of the channel remained to be confirmed by an 
independent method since low-resolution electron crystallogra- 
phy had led to artefactual data for other pore-forming toxins. In 
this study, matrix-assisted laser desorption/ionization time-of- 
flight mass spectrometry (MALDI-TOF-MS) was used to 
measure the mass of the aerolysin oligomer preparation. A mass 
of 333 850 Da was measured, fitting very well with a beptameric 
complex (expected mass: 332 300 Da). These results confirm the 
earlier evidence that the aerolysin oligomer is a heptamer and 
also show that MALDI-TOF mass spectrometry could be a 
valuable tool to study non-covalent association of proteins. 
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1. Introduction 
Aerolysin is representative of a group of toxins that form 
stable homooligomers which are capable of inserting into bio- 
logical membranes to generate channels. Other members of 
the group include the alpha toxins from Staphylococcus aureus 
[2] and Clostridium septicum [3], protective antigen of anthrax 
toxin and the oxygen-labile toxins [4] produced by a great 
many Gram-positive bacteria. All of these proteins have 
been shown to contain high proportions of l-sheet structure 
and may form channels of the porin type (for a review see [5]). 
Aerolysin is secreted by Aeromonas pp. as an inactive dimeric 
precursor that is activated by proteolytic removal of about 40 
amino acids from the C-terminus [6,7]. The toxin is concen- 
trated on the surface of target cells by binding to a specific 
receptor [8]. Activation and concentration lead to oligomer- 
ization, and this is a prerequisite for channel formation [9]. 
The structure of proaerolysin has been solved at 2.8 ,~ resolu- 
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tion [10] and low-resolution images of 2-dimensional mem- 
brane crystals revealed an aerolysin oligomer structure with 
7-fold symmetry [1] suggesting that the pore is built up by 
seven monomers. This unusual molecularity of the channel 
remained, however, to be confirmed by an independent meth- 
od since low-resolution electron crystallography had led to 
artefactual data for other pore-forming toxins [11-13]. Ana- 
lyses by SDS-PAGE as well as by STEM were not accurate 
enough to determine unambiguously the mass [1] and analy- 
tical centrifugation or cross-linking experiments gave conflict- 
ing results (Ausio and Buckley, personal communication). 
Even though the aerolysin oligomeric omplex is not cova- 
lent, it may be suited to analysis by mass spectrometry due to 
its unusual stability. It is not disrupted by guanidine hydro- 
chloride, pH extremes, SDS, reducing agents or heat and it is 
resistant to many proteases [14]. Electrospray ionization mass 
spectrometry (ESMS) [15] has previously been used to char- 
acterise non-covalent receptor-ligand complexes [16], oligonu- 
cleotide associations [17,18], non-covalent protein-peptide 
complexes [19] and more recently to study the tetramers 
formed by avidin [20], streptavidin [21], hemoglobin [20] as 
well as yeast alcohol dehydrogenase and rabbit muscle pyru- 
vate kinase [22]. However, the use of ESMS is usually limited 
to mass measurements below 150 kDa due to the difficulty of 
resolving multiply charged ions at higher mass. Thus com- 
plexes as large as the aerolysin oligomer cannot be studied 
by this method, at least with the instrumentation available 
now.  
In contrast, MALDI-TOF mass spectrometry has been suc- 
cessfully used to measure masses of monomeric proteins great- 
er than 200 kDa [23]. Thanks to its high sensitivity, this tech- 
nique has been shown to be especially well suited for analysis 
of low amounts of biological samples. However, it was ini- 
tially anticipated that it would not yield masses for non-cova- 
lent protein complexes, since initial dilution of samples in the 
matrix solution was thought o lead to the disruption of qua- 
ternary assemblies. Thus, although successful, MALDI-TOF 
mass measurements on small non-covalent complexes have 
been published [24], very few examples of specific oligomeric 
complexes have been studied with this technique [25]. In this 
paper we present the successful mass determination of the 
high molecular weight aerolysin oligomer by MALDI-TOF 
mass spectrometry. It confirms our earlier evidence that the 
oligomer is heptameric. 
2. Materials and methods 
Abbreviations: MALDI-TOF, matrix-assisted laser desorption/ioniza- 2.1. Protein purification 
tion; ESMS, electrospray mass spectrometry. Proaerolysin was purified as previously described [26]. Protein con- 
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centrations were calculated using an absorbance of 2.5 at 280 nm for a 
solution of pure aerolysin at 1 mg/ml [14]. 
2.2. Activation of proaerolysin and preparation of the aerolysin 
oligomer 
Proaerolysin (0.4 mg/ml) was activated by treatment with trypsin 
attached to cross-linked beaded agarose (Sigma, 0.5 units of insoluble 
trypsin per ml of solution) for 1 h at room temperature in a buffer 
containing 150 mM NaCI, 100 mM Tris-HCl, pH 8.4. At this pH, 
aerolysin is unable to oligomerize and therefore does not attach to the 
agarose beads. The sample was then centrifuged in order to pellet he 
trypsin. Complete conversion to the aerolysin form of the toxin was 
confirmed by SDS-PAGE. In order to enable the toxin to oligomerize, 
the aerolysin sample was dialysed against a buffer containing 30 mM 
NaCI, 20 mM HEPES, pH 7.4 for 48 h at room temperature. This 
procedure results in almost complete conversion of the aerolysin di- 
mer [27] to the oligomer as demonstrated by SDS-PAGE. 
2.3. Preparation of the oligomer for mass spectrometry 
The sample of aerolysin oligomer was dialysed overnight against 3 
changes of distilled water at 4°C. The sample was then lyophilised 
using a Speed-Vac. Samples of aerolysin oligomer were prepared for 
analysis by redissolving 40 gg in 10 gl of 0.1% aqueous trifluoroacetic 
acid and diluting to a solution concentration of ~ 2 mM. A 13 mg/ml 
sinapinic acid (Fluka) solution in H20, 0.1% TFA/acetonitrile (1:1) 
was freshly prepared prior to experimentation. 1 gl of a 1 : I mixture 
of sinapinic acid solution with aerolysin solution was applied on the 
stainless-steel probe tip. Samples were then dried under moderate 
vacuum before insertion. 
2.4. Time-of-flight mass spectrometry 
Mass spectrometry was performed using a Bruker (Bremen, Ger- 
many) BIFLEX matrix-assisted laser desorption time-of-flight mass 
spectrometer quipped with the single stage ion source SCOUT with 
an X-Y multisample probe, a gridless reflector and the HIMAS linear 
detector. Ionization is accomplished with the 337 nm beam from a 
nitrogen laser with a repetition rate of 3 Hz. All data were acquired at 
28 kV of acceleration potential in the positive ion mode and with the 
linear detector set to 8-8.5 kV post-acceleration. 
3. Results 
As illustrated in Fig. 1, activation of proaerolysin using 
insoluble trypsin followed by extensive dialysis of the sample 
against a low ionic strength buffer led to a preparation of 
aerolysin oligomers essentially free of dimers. However, we 
cannot preclude that undetectable amounts on SDS-PAGE 
of nicked proaerolysin dimers which did not undergo the oli- 
gomerization reaction and are detectable after the first dialysis 
step (lane 2, Fig. 1) remain in solution at the final stage. 
Measurement of the mass of these oligomers obtained by 
spontaneous oligomerization above a certain protein concen- 
tration threshold in the absence of receptors and membranes 
is relevant only if they are identical to those which are formed 
at the surface of the target cell membranes. There is strong 
experimental evidence which supports this hypothesis. These 
oligomers formed identical channels in lipid planar bilayers as 
upon injection of proaerolysin and trypsin whether or not the 
receptor protein is present [8,28]. There is a complete paral- 
lelism between the loss of biological activity by mutation or 
by the presence of zinc ions and the loss of capacity to form 
oligomers in solution. Finally, we checked that these oligo- 
mers migrated at the same position as those found in the 
erythrocytes membranes after inducing lysis with proaerolysin 
and trypsin (data not shown). 
The MALDI -TOF  spectrum of this aerolysin oligomer 
preparation is shown Fig. 2. Two series of multiply charged 
species are observed. The charge in the first series, corre- 
sponding to the smaller species, labelled M ranges from 1 to 
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Fig. 1. Preparation of oligomeric aerolysin. The aerolysin oligomer 
was prepared as described in section 2. Lane: l, proaerolysin mar- 
ker showing a slight presence of activated aerolysin; 2, sample after 
dialysis against 30 mm NaC1, 20 mM HEPES, pH 7.4; 3, sample 
after dialysis against distilled water, just prior to lyophilization for 
mass spectrometry. The monomers een on lane 2 indicate that a 
small portion of nicked proaerolysin remains as a dimer in solution, 
This dimer is dissociated under the SDS-PAGE experimental condi- 
tions [34]. 
3. The measured mass from the singly charged ion (47 480 Da) 
can be assigned to the aerolysin monomer (expected mass: 
47471 Da based on the amino acid sequence, in agreement 
with our previous mass determinations [7]), A small peak 
corresponding to the aerolysin dimer is also observed. This 
dimer is always present even when measuring the mass of very 
diluted solutions of protein indicating that this is a specific 
complex originating probably from cleaved proaerolysin 
which remains as a dimer in the preparation.The charge in 
the second series of peaks, labelled 7M, ranges from 1 to 4, 
The molecular mass of the singly charged ion in this series is 
333 850 Da, in good agreement with the predicted mass of the 
aerolysin heptamer (expected mass: 332 300 Da). The sharp- 
ness of the peak at 334 kDa (resolution re~Am = 55 where m is 
the mass) allows a rather accurate measurement of the mass. 
This resolution would allow the separation at 50% valley of 
two peaks with a mass difference of 5000 Da. The mass values 
calculated from the three other charge states of 7M (336490, 
335 060, 335 080 Da for 7M 4+, 7M a+ and 7M 2+, respectively) 
are slightly higher, probably because of initial kinetic energy 
inhomogeneities [29]. 
In the MALDI -TOF  spectra we obtained, only ions corre- 
sponding to the monomer, traces of dimers and a heptamer 
were observed. No ions corresponding to alternative degrees 
of association of aerolysin monomers were detectable (tri-, 
tetra-, penta-, hexa-or octameric complexes with calculated 
masses of 143.2, 190.9, 238.6, 286.4 or 381.8 kDa, respec- 
tively). The absence of these species is clearly not due to a 
limitation of the method as 5 kDa differences in molecular 
masses could be resolved. Moreover, the absence of this spe- 
cies strongly suggests that non-specific clusters, which can 
easily be observed in MALDI  provided that the concentration 
of the analyte in the matrix and the fluence are high enough 
[30], are not formed under our experimental conditions. 
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It is interesting to note that aerolysin MALDI-TOF spectra 
could be obtained only at threshold irradiance [25] and within 
a defined concentration window of 1.54).5 pmol/~tl which 
corresponds to an analyte/matrix ratio range from 1/20000 
to 1/50 000. This range is critical because at higher or lower 
analyte/matrix ratio only the monomer and traces of dimer 
were detected. This observation is in agreement with the re- 
sults of Nelson et al. [31] who noted that the higher the ana- 
lyte molecular weight, the smaller the concentration window 
where one can obtain satisfactory results. Nevertheless, within 
this concentration window spectra re remarkably reproduci- 
ble from one experiment to another. 
4. Discussion 
Our results how convincingly that the aerolysin oligomer is 
heptameric, onfirming the prediction made earlier using elec- 
tron microscopy. Until recently this stoichiometry was consid- 
ered rather unusual. However, studies on other pore-forming 
toxins indicate that association as heptamers may be charac- 
teristic of a whole class of channel-forming toxins which have 
substantial I~-sheet structure. The same stoichiometry has been 
found with alpha toxin from S. aureus. This toxin, which has 
little sequence homology to aerolysin but shares a similar 
mode of action, was thought previously to form hexamers 
or tetramers based on electron microscopy [11], analytical 
centrifugation, cross-linking and SDS-PAGE analysis, 
[12,13]. However, X-ray analysis of crystals and an elegant 
charge shift migration assay have recently provided convinc- 
ing evidence that alpha toxin forms a heptamer [32]. It has 
also been recently reported that the oligomeric forms of the 
protective antigen of anthrax toxin [33] as well as that of Vac 
A from Helicabacter pylori (R. Rappuoli, personal communi- 
cation) are both heptamers. 
We have demonstrated that it is possible to observe oligo- 
meric structures formed by specific non-covalent interactions 
using MALDI-TOF mass spectrometry. The fact that the hep- 
tamer was not disrupted by the conditions involved in the 
sample preparation and production of the spectra is further 
evidence of the remarkable stability of this complex and may 
explain the success of the MALDI-TOF method with aeroly- 
sin. It is important to emphasize that the monomer-monomer 
interactions in the aerolysin oligomer are non-covalent since 
the complex can be dissociated when incubated with 70% 
formic acid for 30 min at room temperature. Experiments 
with less stable oligomers will show how generally applicable 
this method may be for the characterisation f non-covalent 
protein subunit associations. As oligomers with very high 
masses uch as the aerolysin oligomer can only be observed 
in a well defined concentration window, we recommend that 
several analyte/matrix ratio be tested by preparing analyte 
solutions ranging from 10 pmol/pl to 0.1 pmol/p]. 
How a dimeric protoxin assembles into a heptameric oligo- 
mer remains a puzzling question that is difficult to address. In 
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Fig. 2. MALDI-TOF mass spectrum of aerolysin heptamer. Measured molecular mass 333850 Da. Less than 500 fmol loaded onto the target 
in sinapinic acid. M, monomer; 7M, heptamer. The arrow indicates a small peak corresponding to traces of aerolysin dimers. 
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this study, pure preformed aerolysin oligomers were analysed 
with success by MALDI -TOF mass spectrometry. This meth- 
od may also prove to be a useful tool to study the assembly 
process of aerolysin into oligomers after activation of the 
protoxin by proteases and to detect intermediates in the asso- 
ciation reaction. 
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